FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan
      Dashboard

      Johnson & Johnson Reports Strong Pharmaceutical Sales Amid Weaker Medical Device Performance

      Johnson & Johnson (J&J) has reported a 7.7% increase in pharmaceutical sales for the latest quarter, reaching $16.76 billion. This growth reflects strong demand for its pharmaceutical products, contributing significantly to the company's overall revenue.

      In contrast, the medical technology division experienced a more modest growth of 2.5%, with sales totaling $8.6 billion. The company attributed this slower performance to ongoing conflicts in the Middle East, which have impacted the medical device market.

      Despite the challenges in the medical technology sector, J&J's overall financial performance exceeded analysts' expectations, highlighting the resilience of its pharmaceutical segment. The company continues to navigate a complex global landscape while maintaining a strong position in the healthcare market.

      © 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

      Source: KLEA News

      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud